Piper Sandler Maintains Overweight on Colgate-Palmolive, Raises Price Target to $96
Colgate-Palmolive Company
Colgate-Palmolive Company CL | 0.00 |
Piper Sandler analyst Michael Lavery maintains Colgate-Palmolive (NYSE:
CL) with a Overweight and raises the price target from $92 to $96.
